Elaboration of simplified vinca alkaloids and phomopsin hybrids

Chemical Biology and Drug Design

Volumn 75, Issue 3, 2010, Pages 284-294

  Ngo, Quoc Anh ^a   Roussi, Fanny ^a   Thoret, Sylviane ^a   Guéritte, Françoise ^a  

^a CNRS   (France)

Author keywords

Phomopsin A; Tubulin; Vinca alkaloids

Indexed keywords

18 3',5' DIMETHOXYANILINECLEAVAMINE; 18 BENZOFURAN NORCLEAVAMINE; 18 METHOXY NORCLEAVAMINE; 18 METHOXYCLEAVAMINE; 5,7 DIMETHOXY 3 METHYL 2,3 DIHYDROBENZOFURAN; ANHYDROVINBLASTINE; N METHYL 5,7 DIMETHOXYINDOLINE; PHOMOPSIN A; UNCLASSIFIED DRUG; VINCA ALKALOID; CATHARANTHINE; METHANOL; MYCOTOXIN; PHOMOPSIN; TUBULIN; TUBULIN MODULATOR; VINBLASTINE; VINDOLINE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MOLECULAR MODEL; POLYMERIZATION; PRIORITY JOURNAL; STEREOCHEMISTRY; ANALOGS AND DERIVATIVES; CHEMISTRY; METABOLISM; STEREOISOMERISM; SYNTHESIS; THERMODYNAMICS;

VINCA;

METHANOL; MYCOTOXINS; STEREOISOMERISM; THERMODYNAMICS; TUBULIN; TUBULIN MODULATORS; VINBLASTINE; VINCA ALKALOIDS;

EID: 76049113063     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00922.x     Document Type: Article

References (27)

1. Kiselyov A., Balakin K.V., Tkachenko S.E., Savchuk N., Ivachtchenko A.V. (2007) Recent progress in discovey, development of antimitotic agents. Anticancer Agents Med Chem 7 : 189 208.
2. Blaskó G., Borman L.S., Cordell G.A., Kuehne M.E., Markó I., McCormack J.J., Neuss N., Pearce H.L. (1990) Antitumor bisindole alkaloids from Catharantus roseus (L.). In : Brossi A. editor. The Alkaloids 37. San Diego, CA : Academic Press Inc. 1 240.
3. Noble R.L., Beer C.T., Cutts J.H. (1958) Role of chance observation in chemotherapy: Vinca Rosea. Ann N Y Acad Sci 76 : 882 894.
4. Svoboda G.H., Neuss N., Gorman M.J. (1959) Alkaloids of Vinca Rosea Linn. V. Preparation and characterization of alkaloids. J Am Pharm Assoc 48 : 659 666.
5. Chen S.-H., Hong J. (2006) Novel tubulin-interacting agents: a tale of Taxus brevifolia and Catharantus roseus-based drug discovery. Drugs Future 31 : 123 150.
6. Guéritte F., Fahy J. (2005) The vinca alkaloids. In : Gragg G.M., Kingston D.G.I., Newman D.J., editors. Anticancer Agents from Natural Products. Boca Raton, FL : Taylor and Francis p. 123 136.
7. Fahy J. (2001) Modifications in the "upper" velbenamine part of the vinca alkaloids have major implications for tubuline interacting activities. Curr Pharm Des 7 : 1181 1197.
8. Gigant B., Wang C., Ravelli B.G.R., Roussi F., Steinmetz M.O., Curmi P.A., Sobel A., Knossow M. (2005) Structural basis for the regulation of tubuline by vinblastine. Nature 435 : 519 522.
9. Cormier A., Marchand M., Ravelli R.B.G., Knossow M., Gigant B. (2008) Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Rep 9 : 1101 1106.
10. Natarajan A., Guo Y., Harbinski F., Fan Y.-H., Chen H., Luus L., Diercks J., Aktas H., Chorev M., Halperin J.A. (2004) Novel arylsulfonamide-oxindole hybrid as an anticancer agent that inhibits translation initiation. J Med Chem 47 : 4979 4982.
11. Ngo Q.A., Roussi F., Cormier A., Thoret S., Knossow M., Guénard D., Guéritte F. (2009) Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids. J Med Chem 52 : 134 142.
12. Potier P., Langlois N., Langlois Y., Guéritte F. (1975) Partial synthesis of vinblastine-type alkaloids. J Chem Soc Chem Commun : 670 671.
13. Langlois N., Guéritte F., Langlois Y., Potier P. (1976) Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J Am Chem Soc 98 : 7017 7024.
14. Mangeney P., Andriamialisoa R.Z., Lallemand J.-Y., Langlois N., Langlois Y., Potier P. (1979) 5′-Nor-anhydrovinblastine. Tetrahedron 35 : 2175 2179.
15. Berry R.W., Shelanski M.L. (1972) Interactions of tubulin with vinblastine and guanosine triphosphate. J Mol Biol 71 : 71 80.
16. Shelanski M.L., Gaskin F., Cantor C.R. (1973) Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A 70 : 765 768.
17. Tempête C., Werner G.H., Favre F., Rojas A., Langlois N. (1995) In vitro cytostatic activity of 9-demethoxyporothramycin B. Eur J Med Chem 30 : 647 650.
18. Sundberg R.J., Gadamasetti K.G., Hunt P.J. (1992) Mechanistic aspects of the formation of anhydrovinblastine by Potier-Polonovski oxidative coupling of catharantine and vindoline. Spectroscopic observation and chemical reactions of intermediates. Tetrahedron 48 : 277 296.
19. Mangeney P. (1979) Ph.D. Dissertation. Orsay, France : University Paris-Sud.
20. Tabakovic I., Ibro E., Gasic M.J. (1996) Anodic C16-C21 fragmentation of catharantine in methanol. Synthesis of 16-methoxycleavamine. J Chem Soc Perkin Trans II 12 : 2741 2746.
21. Andriamialisoa R.Z. (1978) Ph.D. Dissertation. Orsay, France : University Paris-Sud.
22. Magnus P., Mendoza J.S., Stamford A., Ladlow M., Willis P. (1992) Nonoxydative coupling methodology for the synthesis of the antitumor bisindole alkaloids vinblastine and a lower halg analogue: solvents effect on the stereochemistry of the crucial C-15′/C-18′ bond. J Am Chem Soc 114 : 10232 10245.
23. 5 integrin dual inhibitors with improved bioavailability. Selection of the molecular core. J Med Chem 48 : 926 934.
24. Shankaran K., Sloan C.P., Snieckus V. (1985) Synthetic connections to the aromatic directed metalation reaction. Radical-induced cyclisation to substituted benzofurans, benzopyrans and furopyridines. Tetrahedron Lett 50 : 6001 6004.
25. Vukovic J., Goodbody A.E., Kutney J.P., Misawa M. (1988) production of 3′,4′-anhydrovinblastine: a unique chemical synthesis. Tetrahedron 44 : 325 331.
26. Guéritte F., Pouilhes A., Mangeney P., Andriamialisoa R.Z., Langlois N., Langlois Y., Potier P. (1983) Composés antitumoraux du roupe de la vinblastine: dérivés de la nor-5′anhydrovinblastine. Eur J Med Chem 18 : 419 424.
27. Kutney J.P., Gregonis D.E., Imhof R., Itoh I., Jahngen E., Scott A.I., Chan W.K. (1975) Absolute stereochemistry of the bisindole alkaloids of the vinblastine type. Circular dichroism studies. J Am Chem Soc 97 : 5013 5015.